FIGURE

Fig. 8

ID

ZDB-FIG-250609-107

Publication

Kuo et al., 2025 - The histamine pathway is a target to treat hepatic experimental erythropoietic protoporphyria

Other Figures

All Figure Page

Back to All Figure Page

Fig. 8

CCZ reduces MC presence and histamine levels in the female liver and plasma. (A) May-Grunwald Giemsa staining and immunofluorescence staining of mast cell protease 1 (MCP1) on fch/fch and wild-type livers. MCP1 puncta are indicated by white arrows. Expressions of MCP1 puncta are shown as mean percent cell area ± SD (n = 3 livers, 2 image fields/liver). (B) Immunoblot and densitometry analysis of MCP1 in fch/fch and wild-type livers (n = 3 livers/group). CM, Coomassie staining. (C) Histamine levels in the liver and plasma. Data are shown as mean ± SD (n = 6 mice/group). Statistical analysis was performed by 1-way ANOVA test, ∗∗∗∗P < .0001; ∗∗∗P < .001; ∗∗P < .01; ∗P < .05.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Mol Gastroenterol Hepatol